LEAP-X Trademark

Trademark Overview


On Friday, May 5, 2023, a trademark application was filed for LEAP-X with the United States Patent and Trademark Office. The USPTO has given the LEAP-X trademark a serial number of 97923153. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, August 16, 2024. This trademark is owned by BioCentriq, Inc.. The LEAP-X trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing of biopharmaceutical preparations for cell and gene therapy and stem cell therapy

Testing, research, and development of biopharmaceutical preparations for cell and gene therapy and stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy and stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
leap-x

General Information


Serial Number97923153
Word MarkLEAP-X
Filing DateFriday, May 5, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, August 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacturing of biopharmaceutical preparations for cell and gene therapy and stem cell therapy
Pseudo MarkLEAP X
Goods and ServicesTesting, research, and development of biopharmaceutical preparations for cell and gene therapy and stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy and stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 15, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 5, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioCentriq, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, NJ 07103

Trademark Events


Event DateEvent Description
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2023NEW APPLICATION ENTERED
Monday, June 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Wednesday, May 15, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 15, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 15, 2024NON-FINAL ACTION WRITTEN
Thursday, February 15, 2024NON-FINAL ACTION E-MAILED
Thursday, February 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED